More or less for the same reasons i noted aboveConviction Increasing on AMP Cost Saves
While conviction is increasing, AMP still may not fully achieve its cost savings targets, Citi analysts say in a note.
They attributes this partly too its newly announced buyback.
This prompts Citi to lift its earnings per share "significantly," by 19% in FY 2024 and 16% in FY 2025.
This is even as Citi says its forecasts were previously ahead of consensus. Still, Citi sees that AMP looks to have tangible initiatives in place to help it deliver on its cost savings. The stock now looks "more investible," albeit still expensive, it adds, with its main legacy items now dealt with and apparent stability in platform and master trust margins.
- Forums
- ASX - By Stock
- AMP
- Ann: Appendix 4E & 2023 Annual Report
Ann: Appendix 4E & 2023 Annual Report, page-32
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AMP (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.52 |
Change
0.015(1.00%) |
Mkt cap ! $3.848B |
Open | High | Low | Value | Volume |
$1.50 | $1.52 | $1.49 | $8.267M | 5.465M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 84004 | $1.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.53 | 37586 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 84004 | 1.510 |
2 | 219601 | 1.505 |
1 | 36586 | 1.500 |
2 | 100700 | 1.495 |
3 | 16000 | 1.490 |
Price($) | Vol. | No. |
---|---|---|
1.530 | 37586 | 2 |
1.535 | 64586 | 3 |
1.540 | 20250 | 2 |
1.545 | 1002 | 1 |
1.550 | 159516 | 13 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
AMP (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online